FDA accepts Teva's biosimilar filgrastim BLA, Amgen not
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo- filgrastim, short-acting recombinant human granulocyte colony-stimulating factors | Request PDF
Filgrastim-Teva 48 Mio E/0.8ml - xtrapharm
Filgrastim -Teva®
Filgrastim -Teva®
Stability of Hospira filgrastim following changes to thermal and photic storage conditions | PPME
Neulasta rival from Teva cleared in EU - PMLiVE
Filgrastim Biosimilars Market Size, Trends and Global Forecast To 2032
compendium.ch
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma -
Filgrastim-Teva Inj Lös 30 Mio E/0.5ml Fertspr 0.5 ml auf Rezept kaufen | Amavita
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
GRANIX® (tbo-filgrastim) injection
Filgrastim -Teva®
Precio Inmunef 300 mcg jeringa prellenada 5 ml | Farmalisto MX